Valsartan
Brand name: Valsartan
Rank #236 of 500 drugs by total cost
$56.4M
Total Cost
1,481,937
Total Claims
$56.4M
Total Cost
41,149
Prescribers
$38
Cost per Claim
279,682
Beneficiaries
3,608,078
30-Day Fills
$1,370
Avg Cost/Provider
36
Avg Claims/Provider
About Valsartan
Valsartan (sold as Valsartan) was prescribed 1,481,937 times by 41,149 Medicare Part D providers in 2023, costing the program $56.4M. At $38 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 233 | Everolimus (Everolimus) | $57.0M | 8,962 |
| 234 | Allopurinol (Allopurinol) | $56.9M | 3,852,206 |
| 235 | Exenatide Microspheres (Bydureon Bcise) | $56.6M | 48,670 |
| 236 | Valsartan (Valsartan) | $56.4M | 1,481,937 |
| 237 | Benralizumab (Fasenra Pen) | $54.8M | 9,334 |
| 238 | Netarsudil Mesylat/Latanoprost (Rocklatan) | $54.7M | 103,171 |
| 239 | Amifampridine Phosphate (Firdapse) | $54.4M | 1,203 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology